SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 98 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$242,000
-40.4%
27,531
-23.1%
0.00%
-42.9%
Q2 2021$406,000
-52.3%
35,821
-50.0%
0.01%
-53.3%
Q1 2021$851,000
+74.0%
71,631
+0.6%
0.02%
+66.7%
Q4 2020$489,000
+22.6%
71,221
+32.4%
0.01%
-25.0%
Q3 2020$399,000
+94.6%
53,800
+9.3%
0.01%
+20.0%
Q2 2020$205,00049,2000.01%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Prosight Management, LP 908,488$6,232,0002.88%
Knoll Capital Management, LLC 569,405$3,906,0002.66%
Mesirow Financial Investment Management, Inc. 64,698$443,828,0001.40%
Ghost Tree Capital, LLC 650,000$4,459,0000.99%
Johnson & Johnson Innovation - JJDC, Inc. 594,834$4,081,0000.53%
Perceptive Advisors 6,285,458$43,118,0000.46%
Affinity Asset Advisors, LLC 100,000$686,0000.36%
ACUTA CAPITAL PARTNERS, LLC 192,500$1,321,0000.36%
Avidity Partners Management LP 1,435,000$9,844,0000.32%
APOGEM CAPITAL LLC 55,821$383,0000.26%
View complete list of ALDEYRA THERAPEUTICS INC shareholders